Skip to main content
Livermore
Livermore
ZHEN

Man Group plc

SEC CIK
0001637460
Latest filing
Aug 14, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
166,593
Value
$9.34M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RPRX by Man Group plc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026166,593$9.34M<0.1%−235,432−58.6%ReducedHolders
Q1 2026402,025$19.3M<0.1%+13,863+3.6%AddedHolders
Q4 2025388,162$15.0M<0.1%+201,080+107.5%AddedHolders
Q3 2025187,082$6.60M<0.1%+172,844+1,214.0%AddedHolders
Q2 202514,238$513.0K<0.1%−64,673−82.0%ReducedHolders
Q1 202578,911$2.46M<0.1%−736,516−90.3%ReducedHolders
Q4 2024815,427$20.8M0.1%+433,245+113.4%AddedHolders
Q3 2024382,182$10.8M<0.1%−628,286−62.2%ReducedHolders
Q2 20241,010,468$26.6M0.1%+813,343+412.6%AddedHolders
Q1 2024197,125$5.99M<0.1%−2,382,027−92.4%ReducedHolders
Q4 20232,579,152$72.4M0.2%––Holders
Q3 2023–$30.8M0.1%––Holders
Q2 2023578,053$17.8M0.1%––Holders
Q1 2023–$11.0M<0.1%––Holders
Q4 2022321,558$12.7M<0.1%+18,465+6.1%AddedHolders
Q3 2022303,093$12.2M0.1%––Holders
Q2 2022–$15.4M0.1%––Holders
Q1 2022176,115$6.86M<0.1%+135,259+331.1%AddedHolders
Q4 202140,856$1.63M<0.1%+40,856NewHolders
Q2 20210$00.0%−24,232−100.0%Sold outHolders
Q1 202124,232$1.06M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.